drugset / Trial / NCT00479466

Dose-Range Finding Study for MK0893 (0893-008)

NCT00479466

Phase 2 Terminated 342 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to compare MK0893 to metformin or placebo for patients with Type 2 diabetes (Diabetes Mellitus).

Timeline

Start
2007-07
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-0893 Small molecule 20 mg Oral
Subject MK-0893 Small molecule 40 mg Oral
Subject MK-0893 Small molecule 60 mg Oral
Subject MK-0893 Small molecule 80 mg Oral
Comparator Metformin Small molecule 1000 mg